FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to an anti-inflammatory pharmaceutical composition comprising 5-{4-(aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone in crystalline form A, crystalline form G, or as a mixture of said crystalline forms, pharmaceutically acceptable diluent and pharmaceutically acceptable lubricant. Said active substance has a particle diameter of 50 % by volume (d(0.5)) from 3 to 9 microns. Diluent is selected from a group consisting of silicified microcrystalline cellulose, microcrystalline cellulose, cellulose, lactose, and combinations thereof, and the lubricant is talc or stearic acid. Pharmaceutical composition according to the present invention has advantages due to good stability, high dissolution rate, improved uniformity, as well as satisfactory pharmacokinetic properties.
EFFECT: due to these advantages, the pharmaceutical composition according to the present invention is effective in treating inflammation or pain.
8 cl, 10 dwg, 11 tbl, 11 ex
Title |
Year |
Author |
Number |
CRYSTALLINE AZITHROMYCIN L-MALATE MONOHYDRATE AND PHARMACEUTICAL COMPOSITION INCLUDING IT |
2006 |
- Kvon Bo Sung
- Kim Eun Sook
- Kim Khee Cheol
- Jun Sangmin
- Ko Mijang-Sil
- Song Tae Khun
- Kim Khan Kiong
- Sukh Kvi Khiun
- Li Gvansun
|
RU2348644C1 |
STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
2013 |
- Kvon Taek Kvan
- Kim Dong Kho
- Kim Kieong Soo
- Kim Jong Il
- Park Dzae Khiun
- Voo Dzong Soo
|
RU2614382C2 |
ISOLATED ORTHORHOMBIC CRYSTALLINE FORM OF 4-{6-ACETYL-3-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO)PROPOXY]-2-PROPYLPHENOXY}-BUTYRIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
2004 |
- Lok Kennet Uolter
- Roi Dejvid Gregori
|
RU2317979C2 |
PHARMACEUTICAL COMPOSITION OF CARBOXAMIDE INHIBITORS OF HIV INTEGRASE, CONTAINING COMPOSITION WITH CONTROLLED RATE OF RELEASE |
2005 |
- Purkavoos Nazaneen
- Nej Dzhejms R.
- Krjuehjns Marija T.
- Vu Jun'Khuehj
- Palkar Saurabkh A.
|
RU2382648C2 |
CRYSTALLINE CLOPIDOGREL NAPHTALENE SULFONATE OR ITS HYDRATE, METHODS FOR ITS PRODUCING AND PHARMACEUTICAL COMPOSITION |
2004 |
- Jun Sangmin
- Kim Eun Sook
- Kim Khi Seok
- Kvon Bo Sung
- Kim Cheol Kiung
- Kim Khan Kiong
- Sukh Kvi-Khiun
- Li Gvan Sun
|
RU2328501C1 |
NEW AMORPHOUS DISPERSION OF N'-(2-CHLOR-6-METHYL-BENZOYL)HYDRAZIDE OF 4-METHYL-3-QUINOLINE-3-YLETHYNYL-BENZOIC ACID |
2018 |
- Zala, Yashoradzh
- Khanamannavar, Bramkhanand
- Dkharmadkhikari, Nitin
|
RU2777569C2 |
PHARMACEUTICAL COMPOSITION |
2011 |
- Malkhotra Dzhina
- Purandare Dr. Shrinivas Madkhukar
|
RU2589842C2 |
NEW CRYSTALLINE FORM OF 3-(4-(BENZYLOXY)PHENYL)HEX-4-ENOIC ACID DERIVATIVE |
2020 |
- Hwang, Jeong Un
- Kim, Jin Woong
- Lee, Kyu Hwan
- Kim, Eun Young
- Choi, Su Kyoung
|
RU2825215C2 |
PHARMACEUTICAL COMPOSITIONS COMPRISING ATORVASTATIN PREPARED WITHOUT GRANULATION |
2004 |
- Berkielli Al'Fred
- Uoterman Kennet Krejg
- Doehriti Patrik Dehvid
|
RU2314804C2 |
SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUBSTITUTED INDANE, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Lindemann, Christopher
- Stengel, Peter J.
|
RU2772693C1 |